FUB-PB-22
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1800098-36-5 |
Chemical data | |
Formula | C25H17FN2O2 |
Molecular mass | 396.41 g/mol |
|
|
|
FUB-PB-22 is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2]
Legal status
FUB-PB-22 is a Anlage II controlled substance in Germany. It was scheduled in Japan in July 2014.
As of October 2015 FUB-PB-22 is a controlled substance in China.[3]
It is also banned in Sweden.[4]
See also
<templatestyles src="Div col/styles.css"/>
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Cannabinoids
- Designer drugs
- Fluoroarenes
- Indolecarboxylates
- Cannabinoid stubs